Abstract:BACKGROUND & OBJECTIVE:It is well known that the patients with B-Non-Hodgkin's Lymphoma (B-NHL) usually have a poor immune response. CD4(+)CD25(+)-Tregs is a new type of suppressor cell. It plays an important role in the tumor immune suppression. But its distribution and the mechanism of immune suppression in B-NHL are still unknown. The present study was designed to evaluate the proportion of Tregs in peripheral blood of the patients with B-NHL with or without chemotherapy to investigate the mechanism of immune suppression in B-NHL and the effect of chemotherapy on immune system and provide evidence for effective intervention in immune function.METHODS:The peripheral blood was collected from 39 patients with B-NHL before chemotherapy, 32 patients with B-NHL who achieved partial remission (PR) or complete remission (CR) after 4-6 cycles of chemotherapy, and 25 healthy people. The population of CD4(+), CD8(+), CD4(+)CD25(+), and CD4(+)CD25(+)CTLA4(+) T cells was evaluated by flow cytometry.RESULTS:The total number of lymphocyte, the proportion of CD4(+)T cells, and the ratio of CD4/CD8 in the group of B-NHL before chemotherapy was significant less than those of the healthy group (1.3+/-0.39 x 10(9) versus 2.1+/-0.41 x 10(9); 27.5%+/-4.1% versus 32.9%+/-5.8%; 0.9+/-0.21 versus 1.31+/-0.4), but the percentages of CD4(+)CD25(+)-Tregs and CD4(+)CD25(+)CTLA4(+)-T cells were significantly higher than those of the healthy donors (14.7%+/-3.1% versus 8.4%+/-2.5%; 7.4%+/-1.6% versus 5.1%+/-1.4%). In the group of chemotherapy, although the CD4/CD8 ratio (1.19+/-0.3) was almost near to that of the healthy group, the total number of lymphocytes (0.8+/-0.53 x10(9)) was less than those of the other two groups, and the proportions of CD4(+)CD25(+)-Tregs (20.3%+/-4.1%) and CD4(+)CD25(+)CTLA4(+)-T cells (11.5%+/-2.2%) were higher than those of the other two groups.CONCLUSION:The population of CD4(+)CD25(+)-Tregs in peripheral blood of the patients with B-NHL with or without chemotherapy was significantly higher than those in healthy donors, which may be one of the important reasons of immunosuppression in B-NHL.

Study on the subset of T lymphocyte and CD4+CD25+ regulatory cells in peripheral blood of malignancies

CD4~+CD25~+/CD4~+CD25~(high) regulatory cells in peripheral blood of cancer patients

Analysis of NK/T and Treg cell in peripheral blood of patients with different malignancies during the chemotherapy

Study on the subset of T lymphocyte and CD4 + CD25 + regulatory cells in peripheral blood in patients with gastric cancer

A Study on the CD4 + CD25 + Regulatory T Cells in Patients with Gastrointestinal Malignancies

The Profile of CD4+CD25+ T Regulatory Lymphocytes Subpopulation in Patients with Cancer by Flow Cytometry

CD4~+ CD25~+-regulatory T cells in peripheral blood from patients with non small cell lung carcinoma

Changes of CD4+CD25+CD127-regulatory T Cells Level and Clinical Significance in the Peripheral Blood of Patients with Lung Cancer

INVESTIGATION OF REGULATORY T CELLS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER

Expression and significance of CD4+CD25high regulatory T cells in patients with non-small-cell lung cancer

[CD4+ CD25high Regulatory T Cells in Peripheral Blood of Patients with B Cell Non-Hodgkin's Lymphoma].

Increase of Cd4(+)Cd25(High) Regulatory T Cells in the Peripheral Blood of Acute Myeloid Leukemia Patients.

The Detection and Clinical Significance of CD4~+CD25~+ Regulatory T Cells in the Peripheral Blood of Patients with Gastric Cancer

Clinical significance of regulatory T cell in peripheral blood in patients with lung cancer

CD4+ CD25+ T Regulatory Cells in Peripheral Blood of B-NHL Patients with or Without Chemotherapy

Study on the CD4+CD25+FoxP3+ Regulatory Cells in Peripheral Blood of NSCLC Patients

Significance of CD4+CD25+ Regulatory T Cells in Peripheral Blood from Patients with Acute Leukemia

Detection of T Lymphocyte Subsets in the Peripheral Blood of Patients with Advanced Lung Adenocarcinoma

Analysis of CD4+T, CD8+T and Regulatory T Cells in Peripheral Blood from Pancreatic Cancer Patients

Correlation between peripheral blood CD4+CD25high CD127low regulatory T cell and clinical characteristics of patients with non-Hodgkin's lymphoma

Detection and clinical values of CD4 + CD25 + regulatory cells in peripheral blood of patients with malignant tumor aged 80 years old and over